2 Biotech/Pharma Penny Stocks With “Strong Buy” Ratings – And Massive Upside Potential
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
When it comes to the five biotech penny stocks to watch this quarter highlighted in today’s article, the author emphasizes that “These aren’t just names… Read More »There’s Good Reason To Watch These 5 Biotech Penny Stocks This Quarter
“Investors who want the massive potential gains from penny stock investing should focus on those with a real business producing real cash,” advise the authors… Read More »“Real Businesses Producing Real Cash”: 3 Penny Stocks Poised To Benefit From Major Market Trends
Over the course of the past 12 months, Novavax has gone from penny stock status before the pandemic to skyrocketing more than 2,700% over the course of the pandemic thus far.
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
or these five stocks – which include a smaller cap mining company and a small-cap biotech play focused on developing specialty products for underserved patient populations read more!
Small- And Mid-Cap Biotech Picks For 2021 and holdovers from 2020.
“Since we know small-cap stocks are hot and biotech stocks are as well, it might make sense to follow some smaller biotech penny stocks this month,”
“These are five stocks for very aggressive investors looking to get share-count leverage with stocks that have sizable upside potential,” declares the author of today’s… Read More »5 Aggressive Tech Plays Under $10
“These are five stocks for very aggressive investors looking to get share-count leverage with stocks that have sizable upside potential.”